| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 02/28/2001 | EP1077690A1 Use of amyloid inhibitors for modulating neuronal cell death |
| 02/28/2001 | EP1077688A1 Transdermal therapeutic system containing pergolide |
| 02/28/2001 | EP1077687A1 Multiparticulate pharmaceutical form with programmed and timed release and preparation method |
| 02/28/2001 | EP1077686A1 Externally triggered microcapsules |
| 02/28/2001 | EP1077685A2 Novel formulation containing paroxetine |
| 02/28/2001 | EP1077684A1 Effervescent preparations |
| 02/28/2001 | EP1077683A1 Antidepressant therapy |
| 02/28/2001 | EP1077682A2 Novel formulation containing paroxetine |
| 02/28/2001 | EP1077681A1 Pharmaceutical preparation containing levothyroxine sodium |
| 02/28/2001 | EP1077680A1 Method of fabricating a banded prolonged release active agent dosage form |
| 02/28/2001 | EP1077679A1 Improvements relating to encapsulation of bioactive agents |
| 02/28/2001 | EP1077678A1 Mucoadhesive compositions for administration of biologically active agents to animal tissue |
| 02/28/2001 | EP1077677A1 Biologically active composition |
| 02/28/2001 | EP1077676A2 Cyclosporin preparations |
| 02/28/2001 | EP1077663A1 Laminate for application onto an acceptor |
| 02/28/2001 | EP0799027B1 Liposomal interferon hybrid compositions |
| 02/28/2001 | EP0686030B1 Microparticles loaded with antigen and pharmaceutical compositions containing these microparticles. |
| 02/28/2001 | CN1285753A Transdermal delivery of particulate vaccine compositions |
| 02/28/2001 | CN1285751A Antimutagenic compositions for treatment and prevention of photodamage to skin |
| 02/28/2001 | CN1285750A New composition of matter |
| 02/28/2001 | CN1285749A Penetration enhancing and irritation reducing systems |
| 02/28/2001 | CN1285748A Use of 9-deoxy-2', 9-alpha-methano-3-oxa-4,5,6-trinor-3, 7-(1,'3'-interphenylene)-13, 14-dihydro-prostaglandin F, to treat peripheral vascular disease |
| 02/28/2001 | CN1285746A Method and composition of an oral preparation of itraconazole |
| 02/28/2001 | CN1285744A Use of histamine for elevating blood histamine levels |
| 02/28/2001 | CN1285741A Double capsule for the administration of active principles in multiple therepies |
| 02/28/2001 | CN1285740A Masking agent in powder form for pharmaceutical flavours |
| 02/28/2001 | CN1285739A High drug load immediate and modified release oral dosage formulations and process for their production |
| 02/28/2001 | CN1285738A Novel oral dosage form for carvedilol |
| 02/28/2001 | CN1285310A Automatic medicine weighing and feeding device according to prescription |
| 02/28/2001 | CN1285221A Traditional Chinese injection for treating swine erysipelas and preparation process thereof |
| 02/28/2001 | CN1285218A Soft extract medicine for relieving cough and removing heat from the lung |
| 02/28/2001 | CN1285209A Medicine for treating peptic ulcer |
| 02/28/2001 | CN1285192A Process for preparation of coated azithromycin micropill |
| 02/28/2001 | CN1285189A Fluoxetine enteric soluble micro-capsule |
| 02/28/2001 | CN1285188A Thermal formed solid releasing-controlled medicinal composition |
| 02/28/2001 | CN1285187A Bdellovibrio bacteriophagic freeze-dryied powder preparation and productive method thereof |
| 02/28/2001 | CN1285186A Novel preparation for local use |
| 02/28/2001 | CN1062555C Substituted benzyloxy carbonyl guanidine, its prepn. method, and application of the same as medicament and medicament containing the same |
| 02/28/2001 | CN1062468C Jidan (chicken bile) oral liquid and preparation process thereof |
| 02/28/2001 | CN1062461C Senility-resistant health medicine |
| 02/28/2001 | CN1062455C Method for preparation of gargle of sarcandra glabra |
| 02/28/2001 | CN1062454C Inhalant for preventing and remitting acute attack of cardio-cerebral disease and preparation thereof |
| 02/28/2001 | CN1062453C Medicine for preventing and controlling brain angiopathy |
| 02/28/2001 | CN1062452C Fat-reducing granules |
| 02/28/2001 | CN1062450C Fomula and preparation of lactobacillaceau embolus |
| 02/28/2001 | CN1062444C Process for preparation of oral slow-release controlled composition |
| 02/27/2001 | US6194543 Dendritic polypeptides |
| 02/27/2001 | US6194462 Pharmaceutical preparation containing nimesulide for oral administration |
| 02/27/2001 | US6194457 Liquid eye drop composition |
| 02/27/2001 | US6194456 Method for inhibiting inflammation |
| 02/27/2001 | US6194430 Viral treatment |
| 02/27/2001 | US6194401 Pharmaceutical compositions containing cyclosporine and a carrier comprising at least an ester of α-glycerophosphoric acid |
| 02/27/2001 | US6194395 Liquid injectable and oral solid pharmaceutical dosage forms of a mixture or complex of cladribine and a water solubilizer, a cyclodextrin; storage stability |
| 02/27/2001 | US6194392 Administering to a patient suffering from swelling associated with brain tumours involving tissue of the group consisting of underperfused tissue and pathological tissue an antiswelling agent and a hyaluronic acid to aid penetration |
| 02/27/2001 | US6194388 Immunomodulatory oligonucleotides |
| 02/27/2001 | US6194384 Long-acting galenical formulation for GRF peptides |
| 02/27/2001 | US6194381 Therapeutic agent and method for feline AIDS virus infections and feline atopic dermatitis |
| 02/27/2001 | US6194062 Storage wrap material |
| 02/27/2001 | US6194006 Quenching emulsion of drug, polymer and solvent; intermediate, adjusted drying; time-release agents |
| 02/27/2001 | US6194005 Method for preparing a pharmaceutical composition with modified release of the active principle, comprising a matrix |
| 02/27/2001 | US6194004 Dry mix formulation for bisphosphonic acids |
| 02/27/2001 | US6194003 Process for making flurbiprofen lozenges |
| 02/27/2001 | US6194002 Pharmaceutical composition comprising bupropion hydrochloride and fumaric acid |
| 02/27/2001 | US6194001 Tablet dosage form of clavulanic acid and amoxycillin comprising a trehalose excipient |
| 02/27/2001 | US6194000 Analgesic immediate and controlled release pharmaceutical composition |
| 02/27/2001 | US6193999 Gum acacia substituted soft gelatin capsules |
| 02/27/2001 | US6193998 Method for producing liposomes with increased percent of compound encapsulated |
| 02/27/2001 | US6193997 Proteinic drug delivery system using membrane mimetics |
| 02/27/2001 | US6193996 Device for the transdermal delivery of diclofenac |
| 02/27/2001 | US6193995 Herbal mixture for treating nasal congestion |
| 02/27/2001 | US6193994 Locally administrable, biodegradable and sustained-release pharmaceutical composition for periodontitis and process for preparation thereof |
| 02/27/2001 | US6193993 Suppository containing an antidementia medicament |
| 02/27/2001 | US6193991 Nontoxic; controlled release of drugs |
| 02/27/2001 | US6193989 Administering drug comprising ivermectin, benzyl alcohol, polyvinylpyrrolidone, n-methyl-2-pyrrolidone, and glycerin by injecting animal to treat parasite infection |
| 02/27/2001 | US6193986 Storability, water in oil emulsion usable in foods, feeds, cosmetics, medicines, agricultural chemicals, machines and various industrial fields |
| 02/27/2001 | US6193985 Tocopherol compositions for delivery of biologically active agents |
| 02/27/2001 | US6193970 Potentiating local inflammatory or immune response to administration of tumor antigen in mammalian subject by administering tumor antigen in form of tumor cells, or subcellular antigenic material and cytokine or cytokines |
| 02/27/2001 | US6193957 For prophylaxis and therapy of airway hyperresponsiveness or inflammatory reactions, e.g., asthma, allergic rhinitis, allergic dermatitis, allergic conjunctivitis, inflammatory bowel disease or rheumatoid arthritis |
| 02/27/2001 | US6193954 Formulations for pulmonary delivery of dopamine agonists |
| 02/27/2001 | US6193951 Microparticles useful as ultrasonic contrast agents |
| 02/27/2001 | CA2194370C Attenuation of wound healing processes |
| 02/27/2001 | CA2190952C Use of a naphthalenesulfonic acid compound for inhibiting retroviral infection |
| 02/27/2001 | CA2188983C Pure 3r-3'r stereoisomer of zeaxanthin for treating macular degeneration in humans |
| 02/27/2001 | CA2168249C Psoriasis treatment |
| 02/27/2001 | CA2156331C Bovine teat dip |
| 02/27/2001 | CA2142124C Apparatus and methods for forming patterned soft gelatin capsules |
| 02/22/2001 | WO2001012797A2 Method of separating rotavirus variants and live attenuated rotavirus vaccine |
| 02/22/2001 | WO2001012718A1 Polymeric composition for solubilizing poorly water soluble drugs and process for the preparation thereof |
| 02/22/2001 | WO2001012653A1 Stabilisation of freeze-dried cake |
| 02/22/2001 | WO2001012264A2 Topical azathioprine for the treatment of oral autoimmune diseases |
| 02/22/2001 | WO2001012235A2 Targeted artificial gene delivery |
| 02/22/2001 | WO2001012233A2 Sustained release formulation of a peptide |
| 02/22/2001 | WO2001012232A2 Process to make a sustained release formulation |
| 02/22/2001 | WO2001012231A1 Method for delivery of therapeutic agents using a solution of dextrin |
| 02/22/2001 | WO2001012230A1 The nasal transmucosal delivery of peptides conjugated with biocompatible polymers |
| 02/22/2001 | WO2001012229A1 Pharmaceutical compositions for oral and topical administration |
| 02/22/2001 | WO2001012225A1 Water channel opener compositions and medicinal compositions for ophthalmic use |
| 02/22/2001 | WO2001012222A1 Immunological tolerance-induction agent |
| 02/22/2001 | WO2001012221A1 Therapeutic and prophylactic compositions including catalytic biomimetic solids and methods to prepare and use them |
| 02/22/2001 | WO2001012214A2 MYCOPHENOLATE MOFETIL IN ASSOCIATION WITH PEG-IFN-$g(a) |